Content
The Week Ahead In Biotech: Pharma Earnings Pick Up Pace
Week In Review: Three China Biopharmas Announce Plans For Shanghai/Hong Kong IPOs
Article By:
ChinaBio® Today
Read
Saturday, July 20, 2019 5:27 PM EDT
HitGen of Chengdu, a small molecule discovery CRO, was approved for a $97 million IPO on Shanghai's new STAR Exchange and Shenzhen Chipscreen Biosciences, a profitable company, will IPO on Shanghai's STAR Board.
Week In Review: Jibeier Pharma Files To Raise $100 Million In IPO On New Shanghai STAR Board
Article By:
ChinaBio® Today
Read
Sunday, July 7, 2019 12:07 AM EDT
Jibeier Pharma, expects to raise $100 million in the offering. The company, plans to use the funds to build a new drug manufacturing facility and R&D center, and to support its R&D of new drugs along with clinical trials.
Venture Capital-Backed IPOs On Track To Raise Record Amount
Article By:
Early Investing
Read
Sunday, June 30, 2019 1:05 AM EDT
2019 is on track to be the biggest year for venture capital (VC)-backed IPOs since 2008. In the first two months of the second quarter, VC-backed companies raised about $12.72 billion in the public markets over 21 offerings
Week In Review: Tasly Bio Files For $1 Billion Hong Kong IPO
Article By:
ChinaBio® Today
Read
Saturday, June 29, 2019 5:19 PM EDT
Shanghai Tasly Biopharma, the biologics arm of Tasly Pharma, has filed a prospectus for a Hong Kong IPO expected to raise up to $1 billion.
In this article: JNJ
Pre-IPO Coverage: Change Healthcare
Article By:
David Trainer
Read
Thursday, June 27, 2019 6:09 AM EDT
Change Healthcare, a healthcare software platform, is expected to IPO on Thursday, June 27.
In this article: CHNG
The Literally Making Money Edition
Podcast By:
Felix Salmon
Listen
Monday, June 24, 2019 1:40 AM EDT
In this week's podcast we discuss Libra, Facebook’s new cryptocurrency, upzoning, and Beyond Meat’s IPO.
We Should Be Cheering The Volume Of IPOs We Have Now
Crowdstrike IPO: Price At 2X Addressable Market
Article By:
Beth Kindig
Read
Friday, June 21, 2019 1:32 PM EDT
Crowdstrike’s IPO financials sparkle with triple-digit growth percentages across the board, as do many startups going public this year. How does one tell all of these Silicon Valley IPOs apart?
In this article: CRWD